USPTO serial 87183488
VIEDOC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 19, 2019
- Examiner
- YOUNG, THOMAS PAUL
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with VIEDOC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher D. Casavale
Christopher D. Casavale NELSON MULLINS RILEY & SCARBOROUGH LLP301 S. College Street, 23rd FloorIP DepartmentCHARLOTTE, NC 28202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software for conducting clinical trials and electronically manage, review and report clinical trial data; [ Software, namely, software for managing clinical trial management systems; ] Computer software for capturing, managing and reporting data and information in the fields of medical clinical trials and medical research; Computer software for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols; Computer software for medical coding in medical clinical trials and medical research; Computer software for the collection of information and data in medical clinical trials and medical research; Computer software for evaluating and measuring the performance and results of medical clinical trials and medical research; Computer software for managing, organizing and reporting the results of medical clinical trials and medical research; Computer software for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research; Computer software for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management | ACTIVE | Dec 15, 2007 |
| 042 | Software as a service (SaaS) solutions featuring software for capturing, managing and reporting data and information in the fields of medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols; Software as a service (SaaS) solutions featuring software for medical coding in medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for the collection of information and data in medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for evaluating and measuring the performance and results of medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for capturing, managing, organizing and reporting the results of medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; Providing temporary use of online non-downloadable computer software for capturing, managing and reporting data and information in the fields of medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols; Providing temporary use of online non-downloadable computer software for the collection of information and data in medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for evaluating and measuring the performance and results of medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for managing, organizing and reporting the results of medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management | ACTIVE | Dec 15, 2007 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PCG Solutions AB
- Other trademarks owned by PCG Solutions AB
- Other trademarks owned by PCG Solutions AB
- Other trademarks owned by VIEDOC TECHNOLOGIES AB
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named VIEDOC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jun 11, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 11, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 26, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 18, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Feb 19, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 19, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 16, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 15, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 14, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 14, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 13, 2018 | IUAF | USE AMENDMENT FILED | — |
| Dec 13, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 13, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 24, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 29, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 29, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 9, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 24, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 20, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 19, 2018 | ALIE | ASSIGNED TO LIE | — |
| Apr 10, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 5, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 5, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 5, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 27, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 26, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 26, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 29, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 29, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 29, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 24, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 19, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 3, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2016 | NWAP | NEW APPLICATION ENTERED | — |